Clearline Capital’s Coherus Oncology CHRS Stock Holding History

Clearline Capital’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$816K	Hold
2024 Q2	$1.36M	Hold
2024 Q1	$1.87M	Buy
2019 Q2	–	Sell
2019 Q1	$337K	Buy
2018 Q4	$113K	Buy